no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Bioactive analogs that simulate subsets of biological activities of 1α,25(OH)2D3 in osteoblasts
|
Farach-Carson, Mary C. |
|
2001 |
66 |
3-5 |
p. 357-361 5 p. |
article |
2 |
Central role of VDR conformations for understanding selective actions of vitamin D3 analogues
|
Carlberg, Carsten |
|
2001 |
66 |
3-5 |
p. 213-221 9 p. |
article |
3 |
Conformationally restricted mimics of vitamin D rotamers
|
Okamura, William H. |
|
2001 |
66 |
3-5 |
p. 239-247 9 p. |
article |
4 |
Contributions of nuclear architecture and chromatin to vitamin D-dependent transcriptional control of the rat osteocalcin gene
|
Lian, Jane B. |
|
2001 |
66 |
3-5 |
p. 159-170 12 p. |
article |
5 |
Differential activities of 1α,25-dihydroxy-16-ene-vitamin D3 analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis
|
Nakagawa, Kimie |
|
2001 |
66 |
3-5 |
p. 327-337 11 p. |
article |
6 |
Differential regulation of heterodimerization by 1α,25-dihydroxyvitamin D3 and its 20-epi analog
|
Liu, Yan-Yun |
|
2001 |
66 |
3-5 |
p. 203-212 10 p. |
article |
7 |
Different shapes of the steroid hormone 1α,25(OH)2-vitamin D3 act as agonists for two different receptors in the vitamin D endocrine system to mediate genomic and rapid responses☆ 1 1 ☆ Guest Editor: Dr. Satya Reddy, Proceedings of the First International Conference on Chemistry and Biology of Vitamin D Analogs, Brown University, Providence, RI.
|
Norman, Anthony W. |
|
2001 |
66 |
3-5 |
p. 147-158 12 p. |
article |
8 |
24,25-Dihydroxyvitamin D3 and bone metabolism
|
van Leeuwen, Johannes P.T.M. |
|
2001 |
66 |
3-5 |
p. 375-380 6 p. |
article |
9 |
1α,25-dihydroxyvitamin D3 displays divergent growth effects in both normal and malignant cells
|
Rashid, Samantha F |
|
2001 |
66 |
3-5 |
p. 433-440 8 p. |
article |
10 |
Editorial
|
Reddy, G.Satyanarayana |
|
2001 |
66 |
3-5 |
p. 127-128 2 p. |
article |
11 |
Functions of 1α,25-dihydroxyvitamin D3 in mammary gland: from normal development to breast cancer
|
Narvaez, Carmen J |
|
2001 |
66 |
3-5 |
p. 301-308 8 p. |
article |
12 |
Highly active analogs of 1α,25-dihydroxyvitamin D3 that resist metabolism through C-24 oxidation and C-3 epimerization pathways
|
Uskokovic, Milan R. |
|
2001 |
66 |
3-5 |
p. 463-471 9 p. |
article |
13 |
History of the development of new vitamin D analogs: studies on 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy)calcitriol (ED-71)
|
Nishii, Y. |
|
2001 |
66 |
3-5 |
p. 137-146 10 p. |
article |
14 |
25-Hydroxyvitamin D3-1α-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis
|
Cross, Heide S. |
|
2001 |
66 |
3-5 |
p. 287-292 6 p. |
article |
15 |
Interaction of vitamin D analogs with signaling pathways leading to active cell death in breast cancer cells
|
Pirianov, Grisha |
|
2001 |
66 |
3-5 |
p. 309-318 10 p. |
article |
16 |
Metabolism of 1α,25-dihydroxyvitamin D3 and its C-3 epimer 1α,25-dihydroxy-3-epi-vitamin D3 in neonatal human keratinocytes
|
Reddy, G.Satyanarayana |
|
2001 |
66 |
3-5 |
p. 441-450 10 p. |
article |
17 |
Metabolism of 1α,25-dihydroxyvitamin D3 in human promyelocytic leukemia (HL-60) cells: In vitro biological activities of the natural metabolites of 1α,25-dihydroxyvitamin D3 produced in HL-60 cells
|
Sunita Rao, D |
|
2001 |
66 |
3-5 |
p. 423-431 9 p. |
article |
18 |
Metabolites and analogs of 1α,25-dihydroxyvitamin D3: evaluation of actions in bone
|
Kadiyala, Sudha |
|
2001 |
66 |
3-5 |
p. 347-355 9 p. |
article |
19 |
Novel side chain analogs of 1α,25-dihydroxyvitamin D3: design and synthesis of the 21,24-methano derivatives
|
Calverley, Martin J. |
|
2001 |
66 |
3-5 |
p. 249-255 7 p. |
article |
20 |
24,25-(OH)2D3 regulates cartilage and bone via autocrine and endocrine mechanisms
|
Boyan, Barbara D. |
|
2001 |
66 |
3-5 |
p. 363-374 12 p. |
article |
21 |
On becoming a molecular endocrinologist
|
Norman, Anthony W. |
|
2001 |
66 |
3-5 |
p. 129-136 8 p. |
article |
22 |
Overview of regulatory cytochrome P450 enzymes of the vitamin D pathway
|
Omdahl, J.L |
|
2001 |
66 |
3-5 |
p. 381-389 9 p. |
article |
23 |
(23S)- and (23R)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone function as antagonists of vitamin D receptor-mediated genomic actions of 1α,25-dihydroxyvitamin D3
|
Ishizuka, Seiichi |
|
2001 |
66 |
3-5 |
p. 227-237 11 p. |
article |
24 |
Selective inhibition of vitamin D hydroxylases in human keratinocytes 1 1 Abbreviations: VD: vitamin D3; 25(OH)D3: 25-hydroxyvitamin D3; 3H-25(OH)D3: [26,27n-3H] 25-hydroxyvitamin D3; 1α,25(OH)2D3: 1α,25-dihydroxyvitamin D3; 1α,25(OH)2-3epi-D3: 1α,25-dihydroxyvitamin-3-epi-D3; 1α,24(R),25(OH)3D3: 1α,24(R),25-trihydroxyvitamin D3, 1α,25(OH)2-24oxo-D3: 1α,25-dihydroxy-24oxo-vitamin D3; 1α,23(S),25(OH)3-24oxo-D3: 1α,23(S),25-trihydroxy-24oxo-vitamin D3; calcitroic acid: 1α-hydroxy-23-carboxy-24,25,26,27-tetranorvitamin D3; CYP: cytochrome P450; 1α-hydroxylase: 25-hydroxyvitamin D3-1α-hydroxylase; 24-hydroxylase (CYP24), 1α,25-hydroxyvitamin D3-24-hydroxylase; PHK, primary human keratinocytes; KGM: keratinocyte growth medium; HPLC, high performance liquid chromatography; IC50: half-maximum inhibitor concentration; SD: standard deviation.
|
Schuster, I |
|
2001 |
66 |
3-5 |
p. 409-422 14 p. |
article |
25 |
Selective inhibitors of CYP24: mechanistic tools to explore vitamin D metabolism in human keratinocytes
|
Schuster, I |
|
2001 |
66 |
3-5 |
p. 451-462 12 p. |
article |
26 |
Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D3: CYP27 in epidermis completes the set of essential vitamin D3-hydroxylases
|
Schuessler, Monika |
|
2001 |
66 |
3-5 |
p. 399-408 10 p. |
article |
27 |
Synthesis and biological activities of a new series of secosteroids: vitamin D phosphonate hybrids
|
Steinmeyer, Andreas |
|
2001 |
66 |
3-5 |
p. 257-266 10 p. |
article |
28 |
Synthesis and biological characterization of 1α,24,25-trihydroxy-2β-(3-hydroxypropoxy)vitamin D3 (24-hydroxylated ED-71)
|
Hatakeyama, Susumi |
|
2001 |
66 |
3-5 |
p. 267-276 10 p. |
article |
29 |
Systematic studies on synthesis, structural elucidation, and biological evaluation of A-ring diastereomers of 2-methyl-1α,25-dihydroxyvitamin D3 and 20-epi-2-methyl-1α,25-dihydroxyvitamin D3
|
Takayama, Hiroaki |
|
2001 |
66 |
3-5 |
p. 277-285 9 p. |
article |
30 |
The effects of 1α,24(S)-dihydroxyvitamin D2 analog on cancer cell proliferation and cytokine expression
|
Shany, Shraga |
|
2001 |
66 |
3-5 |
p. 319-325 7 p. |
article |
31 |
The 25(OH)D3/1α,25(OH)2D3-24R-hydroxylase: a catabolic or biosynthetic enzyme?
|
Henry, Helen L. |
|
2001 |
66 |
3-5 |
p. 391-398 8 p. |
article |
32 |
The role of phospholipase C-γ1 in 1α,25-dihydroxyvitamin D3 regulated keratinocyte differentiation
|
Xie, Zhongjian |
|
2001 |
66 |
3-5 |
p. 339-345 7 p. |
article |
33 |
The role of vitamin D in prostate cancer
|
Zhao, Xiao-Yan |
|
2001 |
66 |
3-5 |
p. 293-300 8 p. |
article |
34 |
Three-dimensional structure-function relationship of vitamin D and vitamin D receptor model
|
Yamada, Sachiko |
|
2001 |
66 |
3-5 |
p. 177-187 11 p. |
article |
35 |
Vitamin D3 analogs (MC 1288, KH 1060, EB 1089, GS 1558, and CB 1093): studies on their mechanism of action
|
Mäenpää, Pekka H. |
|
2001 |
66 |
3-5 |
p. 223-225 3 p. |
article |
36 |
Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription
|
MacDonald, Paul N |
|
2001 |
66 |
3-5 |
p. 171-176 6 p. |
article |
37 |
Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1α,25-dihydroxyvitamin D3 receptor?☆
|
Mohr, Scott C. |
|
2001 |
66 |
3-5 |
p. 189-201 13 p. |
article |